Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedResults have been posted for the study, including ORR and PFS metrics with follow-up details and posting/submission dates. The page now shows the study as completed and adds related documents such as the Informed Consent Form and Study Protocol/Statistical Analysis Plan.SummaryDifference2%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a non-clinical version update of the page display.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No substantive content changes to the study details are indicated by the provided inputs.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.5.0 replaces the previous v3.4.3 on the page. No obvious changes to the study data or core content are indicated.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check112 days agoChange DetectedRevision update from v3.4.1 to v3.4.2. No visible changes to the study details or page layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.